Company Overview and News
Ron Patterson is a retired computer engineer. He worked in Saudi Arabia for five years, two years at the Ghazlan Power Plant near Ras Tanura…
U.S. drillers added four rigs this week, bringing the nation’s oil rig count to 873 – an increase of 137 oil rigs from one year ago – according to weekly data compiled by Baker Hughes, a GE Company.
NEW YORK (Reuters) - Oil prices rose on Friday on signs of surging demand in China, the world’s No. 2 oil consumer, although prices were headed for a second weekly decline on swelling U.S. inventories and concern that trade wars were curbing economic activity.
BHI GEC GE GNE
In the week ending October 19, 2018, the number of land rigs drilling for oil in the United States totaled 873, an increase of four compared to the previous week and up by 137 compared with a total of 736 a year ago. Including 194 other land rigs drilling for natural gas, there are a total of 1,067 working rigs in the country, up week over week by four and 154 more year over year. The data come from the latest Baker Hughes North American Rotary Rig Count released on Friday afternoon.
CLEVELAND, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that William G. Eline, Vice President - Chief Information Officer, will retire after 40 years of dedicated service. The company has appointed Dinu J. Parel to succeed Mr. Eline in November 2018.
BHI DOV.WI PH DOV
Oil futures rose Friday, with the global benchmark pushing back above $80 a barrel, but remained on track for a weekly stumble as rising U.S. inventories overshadowed concerns about U.S.-Saudi tensions.
Brazil and Petrobras (NYSE:PBR) show something in common with US LTO: even with a lot of debt and desire, and a strong resource base, it is difficult to raise production in the face of high decline rates. It may also be a lesson for the world as oil prices rise and activity picks up; it is by far the most active conventional oil region with many major projects at various stages of completion, but facing delays and schedule crowding so oil production has continued a slow decline, contrary to expectations from last year.
BHI XOM PBR
The September MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
KAAC APA SNSR AND LIT BFIT GXG SIL KRMA GXF CHII EV ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI LNGR COPX QQQC GURU FANG
Risk sentiment stabilised primarily on the back of reports that the Treasury Department will not recommend China be labelled a currency manipulator, along with headlines that Trump and Xi will meet on trade seem to be enough reason for the equity sell-off to cool. But indeed never has so much been riding on the contributions of so few.
In the week ending October 12, 2018, the number of land rigs drilling for oil in the United States totaled 869, an increase of eight compared to the previous week and up by 126 compared with a total of 743 a year ago. Including 193 other land rigs drilling for natural gas and one listed as miscellaneous, there are a total of 1,063 working rigs in the country, up by 11 week over week and up by 116 year over year.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to BHI / Baker Hughes Inc. on message board site Silicon Investor.
as of ET